| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in 3D culture systems for therapeutic discovery and development in brain cancer
|
Wanigasekara, Janith
|
|
|
28 |
2 |
p.
|
artikel
|
| 2 |
Allosteric binding cooperativity in a kinetic context
|
Díaz, Óscar
|
|
|
28 |
2 |
p.
|
artikel
|
| 3 |
Biosimilars versus the originator of follitropin alfa: Randomized controlled trials are still the best way to evaluate their comparative effectiveness in assisted reproduction
|
Venetis, Christos A.
|
|
|
28 |
2 |
p.
|
artikel
|
| 4 |
Brain-derived neurotrophic factor (BDNF) in perinatal depression: Side show or pivotal factor?
|
Singh, Saumya
|
|
|
28 |
2 |
p.
|
artikel
|
| 5 |
Breaking boundaries: Current progress of anticancer NK cell-based drug development
|
Wang, Shuhang
|
|
|
28 |
2 |
p.
|
artikel
|
| 6 |
Contents page
|
|
|
|
28 |
2 |
p.
|
artikel
|
| 7 |
Curcumin in human osteosarcoma: From analogs to carriers
|
Lu, Ko-Hsiu
|
|
|
28 |
2 |
p.
|
artikel
|
| 8 |
Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics
|
Grimaldi, Christine
|
|
|
28 |
2 |
p.
|
artikel
|
| 9 |
Current state of, prospects for, and obstacles to mRNA vaccine development
|
Aljabali, Alaa A.A.
|
|
|
28 |
2 |
p.
|
artikel
|
| 10 |
Docking-based generative approaches in the search for new drug candidates
|
Danel, Tomasz
|
|
|
28 |
2 |
p.
|
artikel
|
| 11 |
Engineered organic nanoparticles to combat biofilms
|
Sheng, Yuze
|
|
|
28 |
2 |
p.
|
artikel
|
| 12 |
Expanding therapeutic strategies for intracellular bacterial infections through conjugates of apoptotic body–antimicrobial peptides
|
Nieto Marín, Valentina
|
|
|
28 |
2 |
p.
|
artikel
|
| 13 |
Gold nanoparticles as antiangiogenic and antimetastatic agents
|
Zamborlin, Agata
|
|
|
28 |
2 |
p.
|
artikel
|
| 14 |
Insight into the pivotal role of signaling pathways in psoriasis pathogenesis, potential therapeutic molecules and drug delivery approaches
|
Tomar, Yashika
|
|
|
28 |
2 |
p.
|
artikel
|
| 15 |
Metabolomics- and systems-biology-guided discovery of metabolite lead compounds and druggable targets
|
Palermo, Amelia
|
|
|
28 |
2 |
p.
|
artikel
|
| 16 |
PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?
|
Zwergel, Clemens
|
|
|
28 |
2 |
p.
|
artikel
|
| 17 |
Peptide-based drug discovery: Current status and recent advances
|
Sharma, Komal
|
|
|
28 |
2 |
p.
|
artikel
|
| 18 |
Polyester-based long acting injectables: Advancements in molecular dynamics simulation and technological insights
|
Kotla, Niranjan G.
|
|
|
28 |
2 |
p.
|
artikel
|
| 19 |
Production of nanostructured systems: Main and innovative techniques
|
Zimmermann, Rafaela
|
|
|
28 |
2 |
p.
|
artikel
|
| 20 |
Promising novel therapeutic targets for kidney disease: Emphasis on kidney-specific proteins
|
Tejeswini Sen, Tathambika
|
|
|
28 |
2 |
p.
|
artikel
|
| 21 |
Recent advances in predicting lncRNA–disease associations based on computational methods
|
Yan, Jing
|
|
|
28 |
2 |
p.
|
artikel
|
| 22 |
Small biotechs versus large pharma: Who drives first-in-class innovation in oncology?
|
Kennedy, Kate H.
|
|
|
28 |
2 |
p.
|
artikel
|
| 23 |
Steps toward nebulization in-use studies to understand the stability of new biological entities
|
Montefusco-Pereira, Carlos Victor
|
|
|
28 |
2 |
p.
|
artikel
|
| 24 |
Strategizing the human microbiome for small molecules: Approaches and perspectives
|
Hussain, Aehtesham
|
|
|
28 |
2 |
p.
|
artikel
|
| 25 |
The clinical supply of cell and gene therapy drugs: Challenges ahead
|
Fehm, Thomas
|
|
|
28 |
2 |
p.
|
artikel
|
| 26 |
The dominant logic of Big Tech in healthcare and pharma
|
Schuhmacher, Alexander
|
|
|
28 |
2 |
p.
|
artikel
|
| 27 |
The gap between development and manufacturing in gene therapy: Strategic options for overcoming traps
|
Nishida, Yu
|
|
|
28 |
2 |
p.
|
artikel
|
| 28 |
Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five
|
Stegemann, Sven
|
|
|
28 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving